Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C. (Q43041286)
Jump to navigation
Jump to search
scientific article published on 17 October 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C. |
scientific article published on 17 October 2011 |
Statements
1 reference
Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C. (English)
1 reference
1 reference
R J de Knegt
1 reference
G Bezemer
1 reference
A R Van Gool
1 reference
J P H Drenth
1 reference
H A Droogleever Fortuyn
1 reference
C J Weegink
1 reference
M W Hengeveld
1 reference
H L A Janssen
1 reference
17 October 2011
1 reference
1 reference
34
1 reference
11-12
1 reference
1306-1317
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference